- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/56 - BenzoxazolesHydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
Patent holdings for IPC class C07D 263/56
Total number of patents in this class: 307
10-year publication summary
15
|
15
|
21
|
17
|
13
|
13
|
14
|
20
|
17
|
11
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Genentech, Inc. | 3976 |
7 |
Janssen Pharmaceutica N.V. | 3394 |
7 |
Theravance Biopharma R&D IP, LLC | 456 |
6 |
F. Hoffmann-La Roche AG | 7947 |
5 |
FUJIFILM Corporation | 29437 |
5 |
The Board of Trustees of the University of Illinois | 2702 |
5 |
CHDI Foundation, Inc. | 106 |
5 |
Shionogi & Co., Ltd. | 852 |
5 |
Biosplice Therapeutics, Inc. | 171 |
5 |
Hoffmann-La Roche Inc. | 3439 |
4 |
Bayer Cropscience AG | 2040 |
4 |
Takeda Pharmaceutical Company Limited | 2708 |
4 |
Nippon Shinyaku Co., Ltd. | 322 |
4 |
BASF SE | 20940 |
3 |
Pfizer Inc. | 3371 |
3 |
Sumitomo Chemical Company, Limited | 9043 |
3 |
Acucela Inc. | 160 |
3 |
bioMerieux | 922 |
3 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 58 |
3 |
King Faisal University | 918 |
3 |
Other owners | 220 |